TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) /

The revenue of TEVA PHARMACEUTICAL INDUSTRIES LIMITED over the past 10 years

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED: revenue, fiscal 2016–2025 Open the chart →

TEVA PHARMACEUTICAL INDUSTRIES LIMITED reported revenue of $17.26B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $21.9B — down 21% over 9 years. Year over year, revenue rose 3 times and fell 6 times. In these years the highest was $21.9B in fiscal 2016; the lowest $14.93B in fiscal 2022. The largest one-year move was in fiscal 2018: down 16%, from $21.85B to $18.27B.

Year by year

Fiscal yearRevenue
2025ended Dec 31, 2025$17.26B
2024ended Dec 31, 2024$16.54B
2023ended Dec 31, 2023$15.85B
2022ended Dec 31, 2022$14.93B
2021ended Dec 31, 2021$15.88B
2020ended Dec 31, 2020$16.66B
2019ended Dec 31, 2019$16.89B
2018ended Dec 31, 2018$18.27B
2017ended Dec 31, 2017$21.85B
2016ended Dec 31, 2016$21.9B

Fiscal years as TEVA PHARMACEUTICAL INDUSTRIES LIMITED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Companies of a similar size

Not investment advice. This page shows what TEVA PHARMACEUTICAL INDUSTRIES LIMITED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.